← Eichor
Study identifier: NCT05817539 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Early Deresuscitation Strategy Driven by Tissue Perfusion in Renal Replacement Therapy in Patients With Acute Renal Failure

Condition: Acute Kidney Injury · Fluid Overload  ·  Sponsor: Hospices Civils de Lyon

PhaseNA
Planned participants250
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

In Intensive Care Unit (ICU) patients with acute kidney injury (AKI) and treated with renal replacement therapy (RRT) often present a fluid overload which is associated with morbidity (mechanical ventilation duration increase, kidney recovery decrease) and mortality. Patients' prognostic could be improved by correcting the fluid overload with net ultrafiltration (UFnet) however it may lead to harmful iatrogenic hypovolemia responsible of deleterious ischemic lesions. In usual practice, UF net prescription are variable and there are different international recommendations. Some observational studies suggest that using a UFnet between 1 et 1.75 mL/kg/h in fluid overloaded patient decrease mortality. Fluid overload increases morbidity and mortality, particularly in RRT. Studies without RRT argue for an efficacy of management by decreasing the fluid overload .Cohort studies suggest to use a moderate UFnet instead of a low UFnet. Some data from studies on early versus late RRT that relate the fluid balance or correct the fluid overload during the early strategy argue for a beneficial effect of an early deresuscitation strategy Consequently, the impact of a moderate UFnet (to decrease the fluid overload) compared to a low UFnet (to stabilize the fluid overload) in a randomized interventional study could be assessed. The study hypothesis is that : an early fluid overload deresuscitation protocol with a high UFnet (2 ml/kg/h) targeting both the negativation of cumulated fluid b…

This description comes directly from the study's public registry record.

Talk to the study team

Matthias JACQUET LAGREZE, MD PhD  ·  04 72 35 79 41  ·  Matthias.jacquet-lagreze@chu-lyon.fr

Julia CANTERINI, project manager  ·  04 27 85 66 28  ·  Julia.canterini@chu-lyon.fr

Always discuss trial participation with your own doctor first.

Locations (14)

Centre Hospitalier d'AjaccioAjaccio, FranceNot Yet Recruiting
CHU Amiens-PicardieAmiens, FranceNot Yet Recruiting
Service d'Anesthesie-Réanimation, Hôpital Louis Pradel, Hospices Civils de LyonBron, FranceRecruiting
CHU Caen NormandieCaen, FranceNot Yet Recruiting
Service de Réanimation, CHU de DijonDijon, FranceRecruiting
GHP Saint Joseph Marie LannelongueLe Plessis-Robinson, FranceNot Yet Recruiting
CHU Lille - Hôpital Roger SalengroLille, FranceNot Yet Recruiting
Hôpital Edouard Herriot, Groupement Hospitalier CentreLyon, FranceRecruiting
Hôpital de la Croix RousseLyon, FranceNot Yet Recruiting
Hôpital de la Croix RousseLyon, FranceRecruiting
Service de Réanimation, Clinique de la SauvegardeLyon, FranceRecruiting
Hôpital Edouard HerriotLyon, FranceNot Yet Recruiting

+ 2 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05817539